acetazolamide has been researched along with Chronic Primary Open Angle Glaucoma in 60 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To confirm the prophylactic effect of oral acetazolamide against increased intraocular pressure (IOP) in the period immediately after cataract surgery in eyes with primary open-angle glaucoma (POAG) and to evaluate the appropriate administration time of oral acetazolamide to prevent IOP elevation." | 9.24 | Prophylactic Effect of Oral Acetazolamide against Intraocular Pressure Elevation after Cataract Surgery in Eyes with Glaucoma. ( Hayashi, K; Manabe, SI; Yoshida, M; Yoshimura, K, 2017) |
| "To investigate the additive ocular hypotensive effect of latanoprost on the intraocular pressure (IOP) reduction induced by a suboptimal dose of acetazolamide, a carbonic anhydrase inhibitor." | 9.08 | Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure. ( Greve, EL; Hoyng, PF; Rulo, AH, 1997) |
| "The study aimed to determine whether topical dorzolamide and systemic acetazolamide have an additive effect on intraocular pressure (IOP) and aqueous humor formation (AHF)." | 9.08 | Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation. ( Hong, PH; Krupin, T; Rosenberg, LF; Ruderman, JM; Tang, LQ, 1998) |
| "To determine in vivo whether a pharmacologically induced change in intraocular pressure (IOP) leads to measurable changes in axial eye length and whether there is a difference between glaucoma patients and control subjects." | 6.24 | Non-invasive biometric assessment of ocular rigidity in glaucoma patients and controls. ( Ebneter, A; Wagels, B; Zinkernagel, MS, 2009) |
| "To confirm the prophylactic effect of oral acetazolamide against increased intraocular pressure (IOP) in the period immediately after cataract surgery in eyes with primary open-angle glaucoma (POAG) and to evaluate the appropriate administration time of oral acetazolamide to prevent IOP elevation." | 5.24 | Prophylactic Effect of Oral Acetazolamide against Intraocular Pressure Elevation after Cataract Surgery in Eyes with Glaucoma. ( Hayashi, K; Manabe, SI; Yoshida, M; Yoshimura, K, 2017) |
| "This study evaluated the effects of acetazolamide, latanoprost, travoprost, bimatoprost, brimonidine, brinzolamide, and timolol on pain during phacoemulsification cataract surgery." | 5.17 | Effect of prophylactic intraocular pressure-lowering medication on pain during cataract surgery. ( Balbaba, M; Çelebi, S; Ulaş, F, 2013) |
| "To investigate the additive ocular hypotensive effect of latanoprost on the intraocular pressure (IOP) reduction induced by a suboptimal dose of acetazolamide, a carbonic anhydrase inhibitor." | 5.08 | Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure. ( Greve, EL; Hoyng, PF; Rulo, AH, 1997) |
| "The study aimed to determine whether topical dorzolamide and systemic acetazolamide have an additive effect on intraocular pressure (IOP) and aqueous humor formation (AHF)." | 5.08 | Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation. ( Hong, PH; Krupin, T; Rosenberg, LF; Ruderman, JM; Tang, LQ, 1998) |
| "Following a timolol and acetazolamide run-in, 105 patients with elevated intraocular pressure (IOP) were randomized to dorzolamide or acetazolamide, in addition to timolol, for 12 weeks." | 5.08 | A comparison of the efficacy and tolerability of dorzolamide and acetazolamide as adjunctive therapy to timolol. Oral to Topical CAI Study Group. ( Adamsons, IA; Hutzelmann, JE; Michael, AJ; Polis, AB, 1998) |
| " The use of systemic acetazolamide provided significant control of IOP and could be considered a 'possible standard' management of cataract surgery in POAG patients." | 3.78 | Short-term changes in intraocular pressure after phacoemulsification in glaucoma patients. ( Centofanti, M; Digiuni, M; Fea, A; Figus, M; Fogagnolo, P; Frezzotti, P; Lembo, A; Ligorio, P; Lorenzi, U; Rossetti, L, 2012) |
| "To investigate the effect of systemic acetazolamide on ocular pulse amplitude (OPA) and on intraocular pressure (IOP)." | 3.75 | Acetazolamide influences ocular pulse amplitude. ( Ebneter, A; Zinkernagel, MS, 2009) |
| "Following the oral administration of three 250-mg doses of acetazolamide sodium to nine patients with glaucomatous visual-field defects, a statistically significant improvement in the differential threshold was observed, whereas in 16 glaucoma suspects, no change could be detected." | 3.66 | Effect of acetazolamide on the differential threshold. ( Drance, SM; Flammer, J, 1983) |
| "From an original group of 36 Patients (15 with relatively advanced chronic open-angle glaucoma and 21 with ocular hypertension) 21 (seven glucoma and 14 ocular hypertension) were well controlled with Timolol alone or in combination with other pressure-lowering drugs after a three years' observation period." | 3.66 | [Long-term therapy with timolol for three years (author's transl)]. ( Bischoff, P; Urner-Bloch, U, 1981) |
| "We compared the intraocular pressure-decreasing effect of timolol maleate alone, acetazolamide alone, and combined timolol and acetazolamide therapy in nine patients with bilateral chronic open-angle glaucoma." | 3.66 | Separate and combined effects of timolol maleate and acetazolamide in open-angle glaucoma. ( Berson, FG; Epstein, DL, 1981) |
| " Dosage and time effects were also determined." | 2.66 | Intraocular pressure effects of carbonic anhydrase inhibitors in primary open-angle glaucoma. ( Lichter, PR; Medzihradsky, F; Musch, DC; Standardi, CL, 1989) |
| "Glaucoma is one of the most frequent causes of blindness in the world." | 2.45 | [Glaucoma]. ( Funk, J, 2009) |
| "Primary open angle glaucoma may be a severe ocular disease and may lead to blindness if not diagnosed and/or treated in time." | 2.40 | [Glaucoma: modern diagnostic and therapeutic approach]. ( Mermoud, A, 1998) |
| "She was treated with acetazolamide for simple glaucoma and since 14 days with ASA for acute pericarditis." | 1.30 | [Salicylism and glaucoma: reciprocal augmentation of the toxicity of acetazolamide and acetylsalicylic acid]. ( De Toffol, MC; Grimbert, M; Hazouard, E; Jonville-Berra, AP; Legras, A, 1999) |
| "Fifty-four eyes of 45 patients with ocular hypertension developed early glaucomatous optic disc or visual field changes after a mean follow-up of 5." | 1.29 | Visual field prognosis in early glaucoma. A long-term clinical follow-up. ( Odberg, T, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (35.00) | 18.7374 |
| 1990's | 19 (31.67) | 18.2507 |
| 2000's | 14 (23.33) | 29.6817 |
| 2010's | 6 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Umfress, AC | 1 |
| Mawn, LA | 1 |
| Joos, KM | 1 |
| Ulaş, F | 1 |
| Balbaba, M | 1 |
| Çelebi, S | 1 |
| Gharbiya, M | 1 |
| Colica, C | 1 |
| Campagna, O | 1 |
| De Vico, U | 1 |
| Cruciani, F | 1 |
| Kaushik, S | 1 |
| Agarwal, A | 1 |
| Kaur, S | 1 |
| Lomi, N | 1 |
| Raj, S | 1 |
| Pandav, SS | 1 |
| Hayashi, K | 1 |
| Yoshida, M | 1 |
| Manabe, SI | 1 |
| Yoshimura, K | 1 |
| Funk, J | 1 |
| Zinkernagel, MS | 2 |
| Ebneter, A | 2 |
| Fogagnolo, P | 1 |
| Centofanti, M | 2 |
| Figus, M | 1 |
| Frezzotti, P | 1 |
| Fea, A | 1 |
| Ligorio, P | 1 |
| Lembo, A | 1 |
| Digiuni, M | 1 |
| Lorenzi, U | 1 |
| Rossetti, L | 1 |
| Elinav, E | 1 |
| Ackerman, Z | 1 |
| Gottehrer, NP | 1 |
| Heyman, SN | 1 |
| Kim, R | 1 |
| Van Stavern, G | 1 |
| Juzych, M | 1 |
| Hamard, P | 1 |
| Loison-Dayma, K | 1 |
| Kopel, J | 1 |
| Hamard, H | 1 |
| Baudouin, C | 1 |
| DRANCE, SM | 2 |
| SHAPIRO, AL | 1 |
| BAUM, JL | 1 |
| Ritland, JS | 2 |
| Egge, K | 3 |
| Lydersen, S | 2 |
| Juul, R | 2 |
| Semb, SO | 2 |
| Viestenz, A | 1 |
| Martus, P | 2 |
| Schlötzer-Schrehardt, U | 1 |
| Langenbucher, A | 1 |
| Mardin, CY | 1 |
| Călugăru, M | 1 |
| Călugăru, D | 1 |
| Vernon, SA | 1 |
| Koppens, JM | 1 |
| Menon, GJ | 1 |
| Negi, AK | 1 |
| Meredith, SP | 1 |
| Swift, L | 1 |
| Eke, T | 1 |
| Broadway, DC | 1 |
| Luntz, MH | 1 |
| Wagels, B | 1 |
| Flammer, J | 1 |
| Skjaerpe, F | 1 |
| Urner-Bloch, U | 1 |
| Bischoff, P | 1 |
| Takki, KK | 1 |
| Klemetti, A | 1 |
| Valle, O | 1 |
| Kass, MA | 1 |
| Korey, M | 1 |
| Gordon, M | 1 |
| Becker, B | 1 |
| Berson, FG | 1 |
| Epstein, DL | 1 |
| Davis, AR | 1 |
| Diggory, P | 1 |
| Seward, HC | 1 |
| Smith, SD | 1 |
| Netland, PA | 1 |
| Odberg, T | 1 |
| Barak, A | 1 |
| Desatnik, H | 1 |
| Ma-Naim, T | 1 |
| Ashkenasi, I | 1 |
| Neufeld, A | 1 |
| Melamed, S | 1 |
| Leys, MJ | 1 |
| van Slycken, S | 1 |
| Nork, TM | 1 |
| Odom, JV | 1 |
| Greenfield, DS | 1 |
| Wanichwecharungruang, B | 1 |
| Liebmann, JM | 1 |
| Ritch, R | 1 |
| Rulo, AH | 1 |
| Greve, EL | 1 |
| Hoyng, PF | 1 |
| Rosenberg, LF | 1 |
| Krupin, T | 2 |
| Tang, LQ | 1 |
| Hong, PH | 1 |
| Ruderman, JM | 1 |
| Mermoud, A | 1 |
| Manni, GL | 1 |
| Napoli, D | 1 |
| Parisi, V | 1 |
| Bucci, MG | 1 |
| Hutzelmann, JE | 1 |
| Polis, AB | 1 |
| Michael, AJ | 1 |
| Adamsons, IA | 1 |
| Hazouard, E | 1 |
| Grimbert, M | 1 |
| Jonville-Berra, AP | 1 |
| De Toffol, MC | 1 |
| Legras, A | 1 |
| Zahl, PH | 1 |
| Gottanka, J | 1 |
| Johnson, DH | 1 |
| Lütjen-Drecoll, E | 1 |
| Stewart, WC | 1 |
| Halper, LK | 1 |
| Johnson-Pratt, L | 1 |
| Polis, A | 1 |
| Hartenbaum, D | 1 |
| Hsieh, JW | 1 |
| West, J | 1 |
| Burke, J | 1 |
| Cunliffe, I | 1 |
| Longstaff, S | 1 |
| Peralta, J | 1 |
| Abelairas, J | 1 |
| Fernández-Guardiola, J | 1 |
| Lumme, P | 1 |
| Tuulonen, A | 2 |
| Airaksinen, PJ | 2 |
| Alanko, HI | 2 |
| Joyce, PW | 1 |
| Mills, KB | 1 |
| Robin, AL | 1 |
| Pillunat, LE | 1 |
| Stodtmeister, R | 1 |
| Lichter, PR | 1 |
| Musch, DC | 1 |
| Medzihradsky, F | 1 |
| Standardi, CL | 1 |
| Begg, IS | 1 |
| Cottle, RW | 1 |
| Koponen, J | 1 |
| Berke, SJ | 1 |
| Bellows, AR | 1 |
| Shingleton, BJ | 1 |
| Richter, CU | 1 |
| Hutchinson, BT | 1 |
| Vodovozov, AM | 1 |
| Boriskina, LN | 1 |
| Håskjold, E | 1 |
| Heller, I | 1 |
| Halevy, J | 1 |
| Cohen, S | 1 |
| Theodor, E | 1 |
| Vela, MA | 1 |
| Campbell, DG | 1 |
| Higgins, RA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Aqueous Humour Release (Burping) Performed at the Slit-lamp to Treat Acute Intraocular Pressure (IOP) Spikes Post-cataract Surgery[NCT03500809] | 20 participants (Anticipated) | Interventional | 2018-08-12 | Not yet recruiting | |||
| Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation (mTSCPC) in Uncontrolled Glaucoma at the University of Montreal Hospital Center (CHUM)[NCT03187418] | 52 participants (Actual) | Interventional | 2017-06-19 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
In micrometer, determined by optical coherence tomography (OCT) (NCT03187418)
Timeframe: 18 months
| Intervention | micrometers (Mean) |
|---|---|
| Micropulse Trans-scleral CPC | 53 |
In micrometer, determined by optical coherence tomography (OCT) (NCT03187418)
Timeframe: 18 months
| Intervention | micrometers (Mean) |
|---|---|
| Micropulse Trans-scleral CPC | 62 |
Progression of CDR compared to baseline, assessed by an ophthalmologist on dilated fundus examination (NCT03187418)
Timeframe: 18 months
| Intervention | ratio (Mean) |
|---|---|
| Micropulse Trans-scleral CPC | 0.82 |
Progression of vertical CDR compared to baseline, assessed by optical coherence tomography (OCT) parameters (NCT03187418)
Timeframe: 18 months
| Intervention | ratio (Mean) |
|---|---|
| Micropulse Trans-scleral CPC | 0.82 |
In millimeters of mercury (mmHg), measured with the Goldmann applanation tonometer (NCT03187418)
Timeframe: 18 months
| Intervention | millimeters of mercury (mm Hg) (Mean) |
|---|---|
| Micropulse Trans-scleral CPC | 15.2 |
Determined by Humphrey automated perimetry Sita 24-2 visual field testing (NCT03187418)
Timeframe: 18 months
| Intervention | decibel (dB) (Mean) |
|---|---|
| Micropulse Trans-scleral CPC | -15.16 |
Number of participants needing a repeat laser treatment during the study (NCT03187418)
Timeframe: 18 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Micropulse Trans-scleral CPC | 10 |
Determined by Humphrey automated perimetry Sita 24-2 visual field testing (NCT03187418)
Timeframe: 18 months
| Intervention | decibel (dB) (Mean) |
|---|---|
| Micropulse Trans-scleral CPC | 7.87 |
Determined by Humphrey automated perimetry Sita 24-2 visual field testing (NCT03187418)
Timeframe: 18 months
| Intervention | percents (Mean) |
|---|---|
| Micropulse Trans-scleral CPC | 57 |
Number of lines reduction or improvement from baseline on Snellen acuity chart at 6 meters (NCT03187418)
Timeframe: 1 week, 1 month, 3 months, 6 months, 12 months, 18 months
| Intervention | LogMAR (Mean) | |||||
|---|---|---|---|---|---|---|
| 1 week | 1 month | 3 months | 6 months | 12 months | 18 months | |
| Micropulse Trans-scleral CPC | 0.81 | 0.84 | 0.79 | 0.77 | 0.79 | 0.82 |
In millimeters of mercury (mmHg), measured with the Goldmann applanation tonometer (NCT03187418)
Timeframe: 1 week, 1 month, 3 months, 6 months, 12 months
| Intervention | millimeters of mercury (mm Hg) (Mean) | ||||
|---|---|---|---|---|---|
| 1 week | 1 month | 3 months | 6 months | 12 months | |
| Micropulse Trans-scleral CPC | 18.2 | 19.2 | 18.6 | 17.9 | 16.7 |
Number of drops and oral medications used by the patient compared to baseline (NCT03187418)
Timeframe: 1 week, 1 month, 3 months, 6 months, 12 months, 18 months
| Intervention | glaucoma medication classes (Mean) | |||||
|---|---|---|---|---|---|---|
| 1 week | 1 month | 3 months | 6 months | 12 months | 18 months | |
| Micropulse Trans-scleral CPC | 3.5 | 3.4 | 3.4 | 3.4 | 3.2 | 3.2 |
Using a verbal analog scale for pain level (none = no subjective feeling of pain, mild = pain easily tolerable, moderate = pain tolerable with difficulty, severe = pain intolerable) (NCT03187418)
Timeframe: 1 day
| Intervention | Participants (Count of Participants) | |||
|---|---|---|---|---|
| None | Mild | Moderate | Severe | |
| Micropulse Trans-scleral CPC | 34 | 12 | 6 | 0 |
6 reviews available for acetazolamide and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
[Glaucoma].
Topics: Acetazolamide; Age Factors; Aged; Carbonic Anhydrase Inhibitors; Child; Child, Preschool; Diagnosis, | 2009 |
[Latanoprost topical ophthalmic combinations].
Topics: Acetazolamide; Administration, Topical; Antihypertensive Agents; Brimonidine Tartrate; Dinoprost; Dr | 2004 |
Diode laser cycloablation in adult glaucoma: long-term results of a standard protocol and review of current literature.
Topics: Acetazolamide; Adolescent; Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Ciliary Bo | 2006 |
Non-invasive biometric assessment of ocular rigidity in glaucoma patients and controls.
Topics: Acetazolamide; Aged; Antihypertensive Agents; Biometry; Cornea; Elasticity; Eye; Female; Glaucoma, O | 2009 |
The role of laser trabeculoplasty as primary therapy for open-angle glaucoma.
Topics: Acetazolamide; Adrenergic beta-Agonists; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Laser T | 1994 |
[Glaucoma: modern diagnostic and therapeutic approach].
Topics: Acetazolamide; Blindness; Carbonic Anhydrase Inhibitors; Glaucoma, Open-Angle; Humans; Laser Therapy | 1998 |
20 trials available for acetazolamide and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Effect of prophylactic intraocular pressure-lowering medication on pain during cataract surgery.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Brimoni | 2013 |
Prophylactic Effect of Oral Acetazolamide against Intraocular Pressure Elevation after Cataract Surgery in Eyes with Glaucoma.
Topics: Acetazolamide; Administration, Oral; Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; | 2017 |
[Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness -- a cross-sectional study on 403 eyes].
Topics: Acetazolamide; Administration, Topical; Adult; Aged; Carbonic Anhydrase Inhibitors; Cloprostenol; Co | 2004 |
GLAUCOMA TREATED WITH DARANIDE A CLINICAL TRIAL.
Topics: Acetazolamide; Aged; Carbonic Anhydrase Inhibitors; Chronic Disease; Dichlorphenamide; Drug Therapy, | 1961 |
Non-invasive biometric assessment of ocular rigidity in glaucoma patients and controls.
Topics: Acetazolamide; Aged; Antihypertensive Agents; Biometry; Cornea; Elasticity; Eye; Female; Glaucoma, O | 2009 |
Timolol and acetazolamide. A study of concurrent administration.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Adult; Aged; Drug Synergism; Drug Ther | 1982 |
Early postoperative intraocular pressure pattern in glaucomatous and nonglaucomatous patients.
Topics: Acetazolamide; Administration, Topical; Adrenergic beta-Antagonists; Aged; Carbonic Anhydrase Inhibi | 1996 |
Acetazolamide affects performance on the Nagel II anomaloscope.
Topics: Acetazolamide; Administration, Oral; Adult; Aged; Carbonic Anhydrase Inhibitors; Color Perception Te | 1996 |
Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Aged; Carbonic Anhydrase Inhibitors; C | 1997 |
Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Adult; Aqueous Humor; Carbonic Anhydra | 1998 |
Hypotensive effects of dorzolamide eyewash in maximal therapy glaucoma patients: a comparative study with oral acetazolamide.
Topics: Acetazolamide; Administration, Oral; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Chronic | 1997 |
A comparison of the efficacy and tolerability of dorzolamide and acetazolamide as adjunctive therapy to timolol. Oral to Topical CAI Study Group.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Adult; Ag | 1998 |
Tolerability and efficacy of dorzolamide versus acetazolamide added to timolol.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Carbon | 2002 |
Effects of timolol and acetazolamide on intraocular pressure elevation following argon laser iridotomy.
Topics: Acetazolamide; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Laser Therapy; Middle Aged; | 1992 |
Prevention of acute postoperative pressure rises in glaucoma patients undergoing cataract extraction with posterior chamber lens implant.
Topics: Acetazolamide; Acetylcholine; Acute Disease; Aged; Aged, 80 and over; Cataract Extraction; Drug Ther | 1992 |
Comparison of the effect of acetazolamide tablets and sustets on diurnal intraocular pressure in patients with chronic simple glaucoma.
Topics: Acetazolamide; Administration, Oral; Circadian Rhythm; Delayed-Action Preparations; Glaucoma, Open-A | 1990 |
Intraocular pressure effects of carbonic anhydrase inhibitors in primary open-angle glaucoma.
Topics: Acetazolamide; Aged; Carbonic Anhydrase Inhibitors; Clinical Trials as Topic; Female; Glaucoma, Open | 1989 |
Epidemiologic approach to open-angle glaucoma: 2. Survival analysis of adverse drug reactions. Report of the Canadian Ocular Adverse Drug Reaction Registry Program. The Collaborative Glaucoma Study Group.
Topics: Acetazolamide; Adult; Age Factors; Aged; Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angl | 1989 |
Laser trabeculoplasty versus medication treatment as primary therapy for glaucoma.
Topics: Acetazolamide; Clinical Trials as Topic; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocula | 1989 |
[Acetazolamide in new formulation forms. A randomized cross-over comparison of Glaupax retard capsules and Diamox Sustex].
Topics: Acetazolamide; Aged; Capsules; Clinical Trials as Topic; Female; Glaucoma, Open-Angle; Humans; Intra | 1985 |
35 other studies available for acetazolamide and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Short-term Optic Disc Cupping Reversal in a Patient With Mild Juvenile Open-angle Glaucoma Due to Early Idiopathic Intracranial Hypertension.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Diet, Reducing; Female; Glaucoma, Open-Angle; Humans; | 2019 |
Urrets- Zavalia Syndrome after glaucoma filtration device implantation.
Topics: Acetazolamide; Aged; Brimonidine Tartrate; Cataract Extraction; Combined Modality Therapy; Drug Resi | 2013 |
Change in Intraocular Pressure in the Fellow Eye After Glaucoma Surgery in 1 Eye.
Topics: Acetazolamide; Adolescent; Adult; Aged; Aged, 80 and over; Female; Glaucoma, Open-Angle; Humans; Int | 2016 |
Acetazolamide influences ocular pulse amplitude.
Topics: Acetazolamide; Administration, Oral; Aged; Blood Flow Velocity; Blood Pressure; Carbonic Anhydrase I | 2009 |
Short-term changes in intraocular pressure after phacoemulsification in glaucoma patients.
Topics: Acetazolamide; Administration, Oral; Aged; Carbonic Anhydrase Inhibitors; Cataract; Glaucoma, Open-A | 2012 |
Recurrent life-threatening acidosis induced by acetazolamide in a patient with diabetic type IV renal tubular acidosis.
Topics: Acetazolamide; Acidosis; Aged; Aged, 80 and over; Bicarbonates; Carbonic Anhydrase Inhibitors; Diabe | 2002 |
Nonarteritic anterior ischemic optic neuropathy associated with acute glaucoma secondary to Posner-Schlossman syndrome.
Topics: Acetazolamide; Acute Disease; Aged; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Female; | 2003 |
[Molteno implant and refractory glaucoma. Evaluation of postoperative IOP control and complications with a modified surgical procedure].
Topics: Acetazolamide; Adult; Aged; Carbonic Anhydrase Inhibitors; Female; Follow-Up Studies; Glaucoma; Glau | 2003 |
The use of sustained release Diamox sequels in the management of open angle glaucoma.
Topics: Acetazolamide; Delayed-Action Preparations; Disease Management; Glaucoma; Glaucoma, Open-Angle | 1961 |
ACUTE OPEN-ANGLE GLAUCOMA IN A PATIENT WITH SICKLE-CELL TRAIT.
Topics: Acetazolamide; Adrenal Cortex Hormones; Anemia; Anemia, Sickle Cell; Drug Therapy; Glaucoma; Glaucom | 1964 |
Exfoliative glaucoma and primary open-angle glaucoma: associations with death causes and comorbidity.
Topics: Acetazolamide; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Cause of Death; Cerebrovascul | 2004 |
Comparison of survival of exfoliative glaucoma patients and primary open-angle glaucoma patients: impact of acetazolamide use.
Topics: Acetazolamide; Age Distribution; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Cause of De | 2004 |
The acute morphologic changes that occur at the optic nerve head induced by medical reduction of intraocular pressure.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Adrenergic alpha-Agonists; Aged; Aged, | 2007 |
Effect of acetazolamide on the differential threshold.
Topics: Acetazolamide; Aged; Differential Threshold; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pre | 1983 |
Selective trabeculectomy. A report of a new surgical method for open angle glaucoma.
Topics: Acetazolamide; Aged; Anterior Chamber; Eye Diseases; Female; Glaucoma; Glaucoma, Open-Angle; Humans; | 1983 |
Medical management of glaucoma.
Topics: Acetazolamide; Adrenal Cortex Hormones; Epinephrine; Glaucoma; Glaucoma, Open-Angle; Humans; Miotics | 1983 |
[Long-term therapy with timolol for three years (author's transl)].
Topics: Acetazolamide; Carbachol; Drug Therapy, Combination; Glaucoma; Glaucoma, Open-Angle; Humans; Intraoc | 1981 |
The IOP-lowering effect of timolol in simple and capsular glaucoma. A multicenter study in Finland.
Topics: Acetazolamide; Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Finland; Glaucoma; Glauc | 1982 |
Separate and combined effects of timolol maleate and acetazolamide in open-angle glaucoma.
Topics: Acetazolamide; Aged; Drug Synergism; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans | 1981 |
Prevalence of chronic hypokalaemia amongst elderly patients using acetozolamide and diuretics.
Topics: Acetazolamide; Aged; Aged, 80 and over; Diuretics; Female; Glaucoma, Open-Angle; Humans; Hypokalemia | 1995 |
Visual field prognosis in early glaucoma. A long-term clinical follow-up.
Topics: Acetazolamide; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Longitudinal S | 1993 |
Pseudotumor cerebri appearing with unilateral papilledema after trabeculectomy.
Topics: Acetazolamide; Adult; Antimetabolites; Carbonic Anhydrase Inhibitors; Female; Fluorouracil; Fundus O | 1997 |
[Salicylism and glaucoma: reciprocal augmentation of the toxicity of acetazolamide and acetylsalicylic acid].
Topics: Acetazolamide; Acidosis; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carbonic Anhydrase Inhibi | 1999 |
Survival of glaucoma patients.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Cause of Death; Female | 1999 |
Marfan syndrome, lens subluxation, and open-angle glaucoma.
Topics: Acetazolamide; Adult; Cataract Extraction; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; | 1999 |
Beta-adrenergic blocker therapy and the trabecular meshwork.
Topics: Acetazolamide; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Aqueous Humor; Drug Therapy, Co | 2001 |
Anaphylactic shock and death after oral intake of acetazolamide.
Topics: Acetazolamide; Administration, Oral; Aged; Anaphylaxis; Female; Glaucoma, Open-Angle; Humans; Intrao | 1992 |
Neuroretinal rim area in low tension glaucoma: effect of nifedipine and acetazolamide compared to no treatment.
Topics: Acetazolamide; Aged; Blood Pressure; Female; Follow-Up Studies; Glaucoma, Open-Angle; Heart Rate; Hu | 1991 |
The role of apraclonidine hydrochloride in laser therapy for glaucoma.
Topics: Acetazolamide; Adult; Aged; Animals; Clonidine; Epinephrine; Female; Glaucoma, Open-Angle; Humans; I | 1989 |
Pressure compliance test of the optic nerve head: influence of different antiglaucoma drugs.
Topics: Acetazolamide; Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Glaucoma, Open-Angle; Hu | 1989 |
Chronic and recurrent choroidal detachment after glaucoma filtering surgery.
Topics: Acetazolamide; Aged; Aged, 80 and over; Choroid; Chronic Disease; Female; Glaucoma, Open-Angle; Huma | 1987 |
[Significance of the intolerance index in glaucoma].
Topics: Acetazolamide; Glaucoma, Open-Angle; Glycerol; Humans; Intraocular Pressure; Prognosis; Visual Field | 1987 |
Significant metabolic acidosis induced by acetazolamide. Not a rare complication.
Topics: Acetazolamide; Acidosis; Aged; Bicarbonates; Chlorides; Female; Glaucoma, Open-Angle; Humans; Hydrog | 1985 |
Hypotony and ciliochoroidal detachment following pharmacologic aqueous suppressant therapy in previously filtered patients.
Topics: Acetazolamide; Aged; Choroid; Ciliary Body; Combined Modality Therapy; Drug Therapy, Combination; Fe | 1985 |
Two years' experience with laser trabeculoplasty.
Topics: Acetazolamide; Argon; Cataract Extraction; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Press | 1985 |